Insurance Coverage for Endoscopic Bariatric Therapies in 2026: Analyses of Top Insurers in the US and Internal Validation

By afschroeder • May 30, 2026

Garcia-Corella J, Shah S, Okafor C, Bechenati D, Arif Y, Bahdi F, Villarruel E, Larios K, Alhanaee M, Thaker A, Rosenthal RJ, Muthusamy VR, Issa D. Insurance Coverage for Endoscopic Bariatric Therapies in 2026: Analyses of Top Insurers in the US and Internal Validation. J Surg Res. 2026 May 28;324:155-161. doi: 10.1016/j.jss.2026.04.039. Epub ahead of print. PMID: 42208214.

Tags: DGSOM Student, Digestive Diseases, endobariatrics, Endoscopic bariatric therapies, Fellow, General Internal Medicine, Insurance, Kern, Obesity, Publications, Resident

Genetic and pharmacologic modulations elucidate NRF2 protective role in acute pancreatitis

Mareninova OA, Chang AG, Hernandez Malpica S, Pineda JA, Mamita R, Shalbueva N, Gukovsky I, Gukovskaya AS. Genetic and pharmacologic modulations elucidate NRF2 protective role[...]

Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset

Yu S, Chen C, Feng J, Li Q, Chen S, Zeng R, Luo D, Huang W, Zhang K, Ma Y, Zhang L, Meng M, Wu[...]

Closing the completion colonoscopy gap: key takeaways from the American Society for Gastrointestinal Endoscopy’s 2025 National Colorectal Cancer Screening Summit

Hosseini-Carroll P, Dominitz JA, Jacobson BC, May FP, Issaka RB, Schmitt CM, Adams TL, Boston IJ, Bucobo JC, Day L, Khaykis IB, Marino MJ, Rex[...]